The University of Texas - Houston Stroke Training Program

这一竞争性更新申请要求为4名博士后培训生提供额外5年的支持， 中风和脑血管疾病，以完成为期2年的奖学金。该计划的使命是开发 神经学家成为中风和脑血管疾病的临床科学家。中风仍然是数字 严重的长期成人残疾的原因之一;迫切需要有效的治疗。的具体目标 培训计划是：（1）提供脑血管病临床和实验室研究的正式培训 疾病在过去5年的资助下，T32培训补助金已导致显着扩大我们的 中风项目变成了一个大学范围的中风研究所。因此，如果再继续提供5年资金， 使我们能够：1）为中风研究员提供不间断的研究指导计划; 2）培训 种族多样的研究人员和医生，科学家谁将对治疗脑血管疾病的影响 疾病我们的总体目标是通过指导临床科学家来改善中风患者的护理， 致力于研究脑血管疾病的病理生理学和流行病学， 将这些知识应用于新的治疗进展和更好的中风护理提供模式。教师的导师 经过精心挑选，提供脑血管疾病的多学科培训经验。 潜在的受训者必须完成神经病学住院医师培训，并表现出对职业生涯的承诺 进行脑血管疾病的研究。

This competitive renewal application requests 5 additional years of support for 4 post-doctoral trainees in stroke and cerebrovascular disease to complete a 2 year fellowship. The program’s mission is to develop neurologists to become clinician-scientists in stroke and cerebrovascular disease. Stroke remains the number one cause of serious long-term adult disability; effective treatments are urgently needed. The specific aims of the training program are to: (1) provide formal training in clinical and laboratory investigation of cerebrovascular disease. The last 5 years of funding under the T32 Training Grant has resulted in significant expansion of our stroke program into a university-wide Stroke Institute. Continued funding for another 5 years would therefore allow us to: 1) provide uninterrupted growth of our research-mentoring program for stroke fellows; 2) train ethnically diverse researchers and physician-scientists who will make an impact on treating cerebrovascular disease. Our overall goal is to improve the care of stroke patients by mentoring clinician-scientists who will dedicate their careers to investigating the pathophysiology and epidemiology of cerebrovascular disease and applying this knowledge to new therapeutic advances and better stroke care delivery models. Faculty mentors have been carefully selected to provide a multidisciplinary training experience in cerebrovascular disease. Potential trainees must have completed a neurology residency and demonstrate a commitment to a career carrying out research in cerebrovascular disease.